ANTI-CD40 ANTIBODY-BINDING MODULATES HUMAN MULTIPLE-MYELOMA CLONOGENICITY IN-VITRO

被引：0

作者：

TONG, AW

SU, D

MUES, G

SOLANO, M

STONE, MJ

机构：

[1] BAYLOR UNIV,BAYLOR SAMMONS CANC CTR,MED CTR,DALLAS,TX

[2] BAYLOR RES INST,M CROWLEY LAB,DALLAS,TX

来源：

BLOOD | 1994年 / 84卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：A170 / A170

页数：1

共 50 条

[31] The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells [J].

Luqman, Mohammad ;

Klabunde, Sha ;

Lin, Karen ;

Georgakis, Georgios V. ;

Cherukuri, Anu ;

Holash, Jocelyn ;

Goldbeck, Cheryl ;

Xu, Xiaomei ;

Kadel, Edward E., III ;

Lee, Sang Hoon ;

Aukerman, Sharon Lea ;

Jallal, Bahija ;

Aziz, Natasha ;

Weng, Wen-Kai ;

Wierda, William ;

O'Brien, Susan ;

Younes, Anas .

BLOOD, 2008, 112 (03) :711-720

[32] ENHANCEMENT OF ANTI-CD54 IMMUNOTOXIN CYTOTOXICITY TO HUMAN MULTIPLE-MYELOMA CELLS BY CYCLOSPORINE DRUGS [J].

TONG, AW ;

HUANG, YW ;

GHETIE, V ;

NEMUNAITIS, J ;

PINEIRO, L ;

VITETTA, E ;

STONE, MJ .

BLOOD, 1994, 84 (10) :A170-A170

[33] Preclinical pharmacokinetics, pharmacodynamics, and activity of a humanized anti-CD40 antibody (SGN-40) in rodents and non-human primates [J].

Kelley, Sean K. ;

Gelzleichter, Thomas ;

Xie, Dong ;

Lee, Wyne P. ;

Darbonne, Walter C. ;

Qureshi, Ferhan ;

Kissler, Kim ;

Oflazoglu, Ezogelin ;

Grewal, Iqbal S. .

BRITISH JOURNAL OF PHARMACOLOGY, 2006, 148 (08) :1116-1123

[34] The novel anti-CD40 monoclonal antibody CFZ533 modulates biomarkers relevant to disease and CD40 pathways in patients with primary Sjogren's syndrome [J].

Fisher, Benjamin ;

Zeher, Margit ;

Ng, Wan-Fai ;

Bombardieri, Michele ;

Posch, Maximilian ;

Papas, Athena S. ;

Farag, Arwa M. ;

Daikeler, Thomas ;

Bannert, Bettina ;

Kivitz, Alan J. ;

Carsons, Steven E. ;

Isenberg, David A. ;

Barone, Francesca ;

Bowman, Simon ;

Espie, Pascal ;

Wieczorek, Grazyna ;

Moulin, Pierre ;

Floch, David ;

Dupuy, Cyrielle ;

Ren, Xiaohui ;

Faerber, Petra ;

Wright, Andrew M. ;

Hockey, Hans Ulrich ;

Rotte, Michael ;

Healey, Margaret ;

Kazma, Remi ;

Sarrazin, Anita Auger ;

Kaiser, Stephanie ;

Mueller, Eric Chen Annemarie ;

Wache-Mainier, Clarisse ;

Macchiarella, Giulio ;

Avrameas, Alexandre ;

Sommer, Ulrike ;

Valentin, Marie-Anne ;

Doucet, Julie ;

Sultan, Marc ;

Schlitt, Thomas ;

Gergely, Peter ;

Rush, James S. .

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (03) :S245-S246

[35] The humanized anti-CD40 monoclonal antibody SGN-40 targets Hodgkin's disease cells through multiple mechanisms. [J].

Law, CL ;

McEarchern, JA ;

Cerveny, CG ;

Smith, LM ;

Nesterova, A ;

Gordon, KA ;

Grewal, IS ;

Wahl, AF .

BLOOD, 2005, 106 (11) :425A-426A

[36] Fc-engineered anti-CD40 antibody enhances multiple effector functions and exhibits potent in vitro and in vivo antitumor activity against hematologic malignancies [J].

Horton, Holly M. ;

Bernett, Matthew J. ;

Peipp, Matthias ;

Pong, Erik ;

Karki, Sher ;

Chu, Seung Y. ;

Richards, John O. ;

Chen, Hsing ;

Repp, Roland ;

Desjarlais, John R. ;

Zhukovsky, Eugene A. .

BLOOD, 2010, 116 (16) :3004-3012

[37] Characterization of the in vitro and in vivo properties of CFZ533, a blocking and non-depleting anti-CD40 monoclonal antibody [J].

Ristov, Jacinda ;

Espie, Pascal ;

Ulrich, Peter ;

Sickert, Denise ;

Flandre, Thierry ;

Dimitrova, Mirela ;

Mueller-Ristig, Dorothee ;

Weider, Doris ;

Robert, Gautier ;

Schmutz, Patrick ;

Greutmann, Barbara ;

Cordoba-Castro, Francisco ;

Schneider, Martin A. ;

Warncke, Max ;

Kolbinger, Frank ;

Cote, Serge ;

Heusser, Christoph ;

Bruns, Christian ;

Rush, James S. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 (12) :2895-2904

[38] Development, validation and application of ELISAs for pharmacokinetic and HACA assessment of a chimeric anti-CD40 monoclonal antibody in human serum [J].

Chowdhury, F. ;

Tutt, A. L. ;

Chan, C. ;

Glennie, M. ;

Johnson, P. W. .

JOURNAL OF IMMUNOLOGICAL METHODS, 2010, 363 (01) :1-8

[39] A phase I dose escalation study of a fully human, antagonist Anti-CD40 antibody, HCD122 (formerly CHIR-12.12) in patients with relapsed and refractory multiple myeloma. [J].

Bensinger, William ;

Jagannath, Sundar ;

Becker, Pamela S. ;

Anderson, Kenneth C. ;

Stadtmauer, Edward A. ;

Aukerman, Lea ;

Fox, Judith ;

Girish, Sandhva ;

Bilic, Sanela ;

Guzy, Serge ;

Solinger, Alan ;

Dort, Sherri ;

Wang, Yongyu ;

Hurst, Deborah .

BLOOD, 2006, 108 (11) :1021A-1021A

[40] CD40 Expression by Human Melanocytic Lesions and Melanoma Cell Lines and Direct CD40 Targeting With the Therapeutic Anti-CD40 Antibody CP-870,893 [J].

Kalbasi, Anusha ;

Fonsatti, Ester ;

Natali, Pier Giorgio ;

Altomonte, Maresa ;

Bertocci, Erica ;

Cutaia, Ornella ;

Calabro, Luana ;

Chiou, Michael ;

Tap, William ;

Chmielowski, Bartosz ;

Maio, Michele ;

Ribas, Antoni .

JOURNAL OF IMMUNOTHERAPY, 2010, 33 (08) :810-816

← 1 2 3 4 5 →